Compare MATH & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MATH | SRTS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.8M | 75.9M |
| IPO Year | 2016 | 2016 |
| Metric | MATH | SRTS |
|---|---|---|
| Price | $1.17 | $3.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 44.9K | ★ 75.4K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | N/A | $38.85 |
| P/E Ratio | $3.10 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.10 | $3.03 |
| 52 Week High | $4.17 | $5.92 |
| Indicator | MATH | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 37.68 |
| Support Level | $1.10 | $3.63 |
| Resistance Level | $3.16 | $4.86 |
| Average True Range (ATR) | 0.07 | 0.26 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 20.00 | 1.56 |
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.